<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(12)</volume><submitter>Hanudel MR</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>National Institutes of Health</funding><journal>Kidney international reports</journal><pagination>1742-1748</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6895647</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients.</pubmed_title><pmcid>PMC6895647</pmcid><funding_grant_id>UL1 TR001102</funding_grant_id><funding_grant_id>R01-DK094796</funding_grant_id><funding_grant_id>K08-DK111980</funding_grant_id><funding_grant_id>R01 DK044863</funding_grant_id><pubmed_authors>Chapman AB</pubmed_authors><pubmed_authors>Salusky IB</pubmed_authors><pubmed_authors>Brosnahan GM</pubmed_authors><pubmed_authors>You Z</pubmed_authors><pubmed_authors>Chonchol MB</pubmed_authors><pubmed_authors>Perrone RD</pubmed_authors><pubmed_authors>Bae KT</pubmed_authors><pubmed_authors>Nowak KL</pubmed_authors><pubmed_authors>Hanudel MR</pubmed_authors><pubmed_authors>Pereira RC</pubmed_authors><pubmed_authors>Torres VE</pubmed_authors><pubmed_authors>Gitomer BY</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Steinman TI</pubmed_authors></additional><is_claimable>false</is_claimable><name>Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients.</name><description/><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2024-12-04T12:05:08.119Z</modification><creation>2024-12-04T12:05:08.119Z</creation></dates><accession>S-EPMC6895647</accession><cross_references><pubmed>31844811</pubmed><doi>10.1016/j.ekir.2019.08.010</doi></cross_references></HashMap>